AB’nin Y\u00fcr\u00fctme Kolu S\u00f6zc\u00fcs\u00fc Stefan De Keersmaecker, AB ve AstraZeneca ortas\u0131ndaki davada ya\u015fanan son geli\u015fmeler hakk\u0131nda, “\u00dcye devletlerde a\u015f\u0131laman\u0131n devam edebilmesi i\u00e7in acil a\u015f\u0131ya muhta\u00e7l\u0131k duyuluyor. Bu sebeple, Avrupa Komitesi mahkemeden \u015firketin k\u00e2fi say\u0131da doz temin etmesini talep etti. ” a\u00e7\u0131klamas\u0131n\u0131 yapt\u0131.<\/p>\n
Mahkemenin, AB\u2019nin a\u015f\u0131 temini hakk\u0131ndaki tezlerini \u00f6n\u00fcm\u00fczdeki haftalarda de\u011ferlendirmesi ve AstraZeneca’n\u0131n kontrat kurallar\u0131n\u0131 ihlal edip etmedi\u011fini ise bu y\u0131l i\u00e7inde incelemesi bekleniyor.<\/p>\n
AB ge\u00e7en y\u0131l AstraZeneca\u2019dan toplam 300 milyon doz a\u015f\u0131 sipari\u015f etmi\u015f, birinci g\u00f6nderilecek doz \u00f6l\u00e7\u00fcs\u00fc i\u00e7in 120 milyonda karar kal\u0131nm\u0131\u015ft\u0131. Ancak, \u015firket AB\u2019ye birinci \u00e7eyrekte sadece 30 milyon doz a\u015f\u0131 g\u00f6ndermi\u015f ve gecikmenin Avrupa\u2019daki tesislerde ya\u015fanan \u00fcretim zorluklar\u0131ndan kaynakland\u0131\u011f\u0131n\u0131 arg\u00fcman etmi\u015fti.<\/p>\n
Tedarik konusunda ya\u015fanan uyu\u015fmazl\u0131\u011f\u0131n yan\u0131 s\u0131ra, AstraZeneca\u2019n\u0131n geli\u015ftirdi\u011fi Kovid-19 a\u015f\u0131s\u0131n\u0131n p\u0131ht\u0131la\u015fmaya sebep oldu\u011fu tezleri nedeniyle, birtak\u0131m AB \u00fcyeleri a\u015f\u0131n\u0131n kullan\u0131m\u0131n\u0131 belli ya\u015f k\u00fcmeleriyle sonland\u0131rm\u0131\u015ft\u0131. Bu sebeple 448 milyon n\u00fcfuslu Avrupa Birli\u011fi, a\u015f\u0131lamada yava\u015f bir ba\u015flang\u0131\u00e7 \u200b\u200byapm\u0131\u015f ve a\u015f\u0131 tedarikine ait belirsizlikler nedeniyle \u00fcye \u00fclkelerin ekonomik faaliyetleri sekteye u\u011fram\u0131\u015ft\u0131.<\/p>\n
AB, a\u015f\u0131 tedarikinde AstraZeneca ile ya\u015fad\u0131\u011f\u0131 uyu\u015fmazl\u0131\u011f\u0131n isminden, Pfizer\/BioNTech firmalar\u0131n\u0131n geli\u015ftirdi\u011fi Kovid-19 a\u015f\u0131s\u0131na y\u00f6neldi. AB ge\u00e7en hafta yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, Pfizer\/BioNTech\u2019den 900 milyon dozu opsiyonlu olmak \u00fczere toplam 1,8 milyar doz daha a\u015f\u0131 sat\u0131n ald\u0131\u011f\u0131n\u0131 bildirdi.<\/p>\n<\/p>\n
Bloomberg HT<\/span><\/p>\n AB’nin Y\u00fcr\u00fctme Kolu S\u00f6zc\u00fcs\u00fc Stefan De Keersmaecker, AB ve AstraZeneca ortas\u0131ndaki davada ya\u015fanan son geli\u015fmeler hakk\u0131nda, “\u00dcye devletlerde …<\/p>\n","protected":false},"author":1,"featured_media":33768,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[196,2254,226,113,271],"class_list":["post-33767","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ekonomi","tag-asi","tag-astrazeneca","tag-doz","tag-milyon","tag-yas"],"yoast_head":"\n